Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
350 USD | +1.63% | +3.09% | -3.12% |
May. 03 | Declaration of Voting Results by Molina Healthcare, Inc | CI |
Apr. 30 | TD Cowen Adjusts Price Target on Molina Healthcare to $412 From $453, Keeps Buy Rating | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The stock, which is currently worth 2024 to 0.43 times its sales, is clearly overvalued in comparison with peers.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.12% | 20.18B | B- | ||
-3.69% | 463B | B- | ||
+17.20% | 98.67B | B- | ||
+4.64% | 40.48B | B- | ||
-26.90% | 39.06B | A- | ||
-12.59% | 3.09B | C+ | ||
-19.74% | 1.3B | B- | ||
-9.33% | 432M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MOH Stock
- Ratings Molina Healthcare, Inc.